Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;24(2):253-265.
doi: 10.2174/1389201023666220506105026.

The Role of VEGF Family in Lipid Metabolism

Yan Zhou  1   2 , Xueping Zhu  1 , Huan Wang  1 , Chenglin Duan  1 , Hanming Cui  1 , Jingjing Shi  1 , Shuai Shi  1 , Guozhen Yuan  1 , Yuanhui Hu  1
Affiliations

The Role of VEGF Family in Lipid Metabolism

Yan Zhou et al. Curr Pharm Biotechnol. 2023.

Abstract

The vascular endothelial growth factor (VEGF) family plays a major role in tumors and ophthalmic diseases. However, increasingly more data reported its potential in regulating lipids. With its biological functions mainly expressed in lymphatic vessels, some factors in the families, like VEGF-A and VEGF-C, have been proved to regulate intestinal absorption of lipids by affecting chylous ducts. Other effects, including regulating lipoprotein lipase (LPL), endothelial lipase (EL), and recombinant syndecan 1 (SDC1), have also been confirmed. However, given the scant-related studies, further research should be conducted to examine the concrete mechanisms and provide pragmatic ways to apply them in the clinic. The VEGF family may treat dyslipidemia in specific ways that are different from common methods and concurrently contribute to the treatment of other metabolic diseases, like diabetes and obesity.

Keywords: VEGF; adipose tissue; atherosclerosis; intestine; lipid metabolism; lipoprotein lipase.

PubMed Disclaimer

References

    1. Pan L.; Yang Z.; Wu Y.; Yin R.X.; Liao Y.; Wang J.; Gao B.; Zhang L.; The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis 2016,248,2-9 - DOI - PubMed
    1. Kopin L.; Lowenstein C.; Dyslipidemia. Ann Intern Med 2017,167(11),ITC81-ITC96 - DOI - PubMed
    1. Kalish B.T.; Fell G.L.; Nandivada P.; Puder M.; Clinically relevant mechanisms of lipid synthesis, transport, and storage. JPEN J Parenter Enteral Nutr 2015,39(1)(Suppl.),8S-17S - DOI - PubMed
    1. Zhou Y.; Zhu X.; Cui H.; Shi J.; Yuan G.; Shi S.; Hu Y.; The role of the VEGF family in coronary heart disease. Front Cardiovasc Med 2021,8,738325 - DOI - PubMed
    1. Gunasekaran B.; Shukor M.Y.; HMG-CoA reductase as target for drug development. Methods Mol Biol 2020,2089,245-250 - DOI - PubMed

Substances

LinkOut - more resources